Stocksigma LogoStocksigma Logo

India Glycols Demerger Operational, Q2 FY27 Post-Demerger Revenue Rises 30% YoY

India Glycols Limited released its Q2 & H1 FY27 presentation following the demerger of its spirits and biopharma arms, effective 1st Sep'26

India Glycols Demerger Operational, Q2 FY27 Post-Demerger Revenue Rises 30% YoY

India Glycols Ltd · Investor Presentation · 18 Nov 2026, 9:07 pm

India Glycols Demerger Operational, Q2 FY27 Post-Demerger Revenue Rises 30% YoY India Glycols Limited released its Q2 & H1 FY27 presentation following the demerger of its spirits and biopharma arms, effective 1st Sep'26. On a like-for-like basis, Q2 FY27 revenue grew 30% YoY to ₹358 Cr, while EBITDA increased 26% YoY to ₹52 Cr. Reported consolidated Q2 FY27 revenue from operations stood at ₹362 Cr with PAT of ₹24 Cr. H1 FY27 like-for-like revenue grew 26% YoY to ₹713 Cr with EBITDA of ₹113 Cr. Over 4–5 years, the company targets ₹2,000 Cr revenue and ₹400 Cr EBITDA.

Original exchange filing (PDF)

More announcements from India Glycols Ltd

All India Glycols Ltd announcements